{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:14:44Z","timestamp":1793812484252,"version":"4.6.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"DOI":"10.1186\/s12987-025-00628-x","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T15:00:57Z","timestamp":1739286057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Blood-CSF barrier clearance of ABC transporter substrates is suppressed by interleukin-6 in lupus choroid plexus spheroids"],"prefix":"10.1186","volume":"22","author":[{"given":"Joshua A.","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola","family":"Torz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Cummins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel D","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayal","family":"Ben-Zvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim","family":"Putterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"628_CR1","doi-asserted-by":"crossref","unstructured":"Nusbaum JS, Mirza I, Shum J, Freilich RW, Cohen RE, Pillinger MH et al. Sex Differences in Systemic Lupus Erythematosus: Epidemiology, Clinical Considerations, and Disease Pathogenesis. Mayo Clin Proc. 2020;95(2):384\u2013\u200994.","DOI":"10.1016\/j.mayocp.2019.09.012"},{"issue":"2","key":"628_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/art.38238","volume":"66","author":"EC Somers","year":"2014","unstructured":"Somers EC, Marder W, Cagnoli P, Lewis EE, DeGuire P, Gordon C, et al. Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program. Arthritis Rheumatol. 2014;66(2):369\u201378.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"628_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","volume":"10","author":"H Jeltsch-David","year":"2014","unstructured":"Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol. 2014;10(10):579\u201396.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"628_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12916-015-0269-8","volume":"13","author":"S Kivity","year":"2015","unstructured":"Kivity S, Agmon-Levin N, Zandman-Goddard G, Chapman J, Shoenfeld Y. Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med. 2015;13(1):43.","journal-title":"BMC Med"},{"issue":"1","key":"628_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/art.40591","volume":"71","author":"JG Hanly","year":"2019","unstructured":"Hanly JG, Kozora E, Beyea SD, Birnbaum J. Nervous system disease in systemic Lupus Erythematosus: current status and future directions. Arthritis Rheumatol. 2019;71(1):33\u201342.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"628_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","volume":"15","author":"N Schwartz","year":"2019","unstructured":"Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol. 2019;15(3):137\u201352.","journal-title":"Nat Rev Rheumatol"},{"key":"628_CR7","doi-asserted-by":"crossref","unstructured":"Monahan RC, Inglese F, Middelkoop H, van Buchem M, Huizinga TW, Kloppenburg M et al. White matter hyperintensities associate with cognitive slowing in patients with systemic lupus erythematosus and neuropsychiatric symptoms. RMD Open. 2021;7(2).","DOI":"10.1136\/rmdopen-2021-001650"},{"issue":"1","key":"628_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.semarthrit.2009.08.005","volume":"40","author":"WL Sibbitt Jr","year":"2010","unstructured":"Sibbitt WL Jr., Brooks WM, Kornfeld M, Hart BL, Bankhurst AD, Roldan CA. Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum. 2010;40(1):32\u201352.","journal-title":"Semin Arthritis Rheum"},{"key":"628_CR9","doi-asserted-by":"crossref","unstructured":"Lindblom J, Mohan C, Parodis I. Biomarkers in neuropsychiatric systemic lupus erythematosus: a systematic literature review of the last decade. Brain Sci. 2022;12(2).","DOI":"10.3390\/brainsci12020192"},{"issue":"4","key":"628_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.autrev.2018.12.004","volume":"18","author":"NP Duarte-Delgado","year":"2019","unstructured":"Duarte-Delgado NP, V\u00e1squez G, Ortiz-Reyes BL. Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus. Autoimmun rev. 2019;18(4):426\u201332.","journal-title":"Autoimmun rev"},{"key":"628_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.expneurol.2015.02.032","volume":"267","author":"R Spector","year":"2015","unstructured":"Spector R, Keep RF, Robert Snodgrass S, Smith QR, Johanson CE. A balanced view of choroid plexus structure and function: focus on adult humans. Exp Neurol. 2015;267:78\u201386.","journal-title":"Exp Neurol"},{"issue":"4","key":"628_CR12","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1152\/physrev.00004.2013","volume":"93","author":"HH Damkier","year":"2013","unstructured":"Damkier HH, Brown PD, Praetorius J. Cerebrospinal fluid secretion by the Choroid Plexus. Physiol Rev. 2013;93(4):1847\u201392.","journal-title":"Physiol Rev"},{"issue":"3","key":"628_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00401-018-1807-1","volume":"135","author":"JF Ghersi-Egea","year":"2018","unstructured":"Ghersi-Egea JF, Strazielle N, Catala M, Silva-Vargas V, Doetsch F, Engelhardt B. Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease. Acta Neuropathol. 2018;135(3):337\u201361.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"628_CR14","doi-asserted-by":"publisher","first-page":"e1251384","DOI":"10.1080\/21688370.2016.1251384","volume":"4","author":"C Sturgeon","year":"2016","unstructured":"Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016;4(4):e1251384\u2013e.","journal-title":"Tissue Barriers"},{"key":"628_CR15","doi-asserted-by":"crossref","unstructured":"Gameiro M, Silva R, Rocha-Pereira C, Carmo H, Carvalho F, Bastos ML et al. Cellular models and in Vitro assays for the screening of modulators of P-gp, MRP1 and BCRP. Molecules. 2017;22(4).","DOI":"10.3390\/molecules22040600"},{"key":"628_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaut.2018.03.001","volume":"91","author":"S Gelb","year":"2018","unstructured":"Gelb S, Stock AD, Anzi S, Putterman C, Ben-Zvi A. Mechanisms of neuropsychiatric lupus: the relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier. J Autoimmun. 2018;91:34\u201344.","journal-title":"J Autoimmun"},{"key":"628_CR17","doi-asserted-by":"crossref","unstructured":"Stock AD, Der E, Gelb S, Huang M, Weidenheim K, Ben-Zvi A et al. Tertiary lymphoid structures in the choroid plexus in neuropsychiatric lupus. JCI Insight. 2019;4(11).","DOI":"10.1172\/jci.insight.124203"},{"key":"628_CR18","doi-asserted-by":"crossref","unstructured":"Gueye M, Preziosa P, Ramirez GA, Bozzolo EP, Canti V, Margoni M et al. Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus. Mol Psychiatry. 2023.","DOI":"10.1038\/s41380-023-02332-4"},{"key":"628_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbi.2023.11.036","volume":"116","author":"B Bravi","year":"2023","unstructured":"Bravi B, Melloni EMT, Paolini M, Palladini M, Calesella F, Servidio L, et al. Choroid plexus volume is increased in mood disorders and associates with circulating inflammatory cytokines. Brain Behav Immun. 2023;116:52\u201361.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"628_CR20","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/art.22451","volume":"56","author":"H Fragoso-Loyo","year":"2007","unstructured":"Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narv\u00e1ez A, D\u00e1vila-Maldonado L, Atisha-Fregoso Y, Llorente L, et al. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum. 2007;56(4):1242\u201350.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"628_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/096120330000900704","volume":"9","author":"E Trysberg","year":"2000","unstructured":"Trysberg E, Carlsten H, Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus. 2000;9(7):498\u2013503.","journal-title":"Lupus"},{"key":"628_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.toxrep.2021.03.002","volume":"8","author":"A Shimada","year":"2021","unstructured":"Shimada A, Hasegawa-Ishii S. Increased cytokine expression in the choroid plexus stroma and epithelium in response to endotoxin-induced systemic inflammation in mice. Toxicol Rep. 2021;8:520\u20138.","journal-title":"Toxicol Rep"},{"issue":"11","key":"628_CR23","doi-asserted-by":"publisher","first-page":"6164","DOI":"10.4049\/jimmunol.171.11.6164","volume":"171","author":"M Bruewer","year":"2003","unstructured":"Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol. 2003;171(11):6164\u201372.","journal-title":"J Immunol"},{"issue":"3","key":"628_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0169-409X(00)00048-X","volume":"41","author":"SV Walsh","year":"2000","unstructured":"Walsh SV, Hopkins AM, Nusrat A. Modulation of tight junction structure and function by cytokines. Adv Drug Deliv Rev. 2000;41(3):303\u201313.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"628_CR25","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.autrev.2014.08.015","volume":"13","author":"H Jeltsch-David","year":"2014","unstructured":"Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: the MRL-lpr mouse strain as a model. Autoimmun Rev. 2014;13(9):963\u201373.","journal-title":"Autoimmun Rev"},{"key":"628_CR26","doi-asserted-by":"publisher","first-page":"207504","DOI":"10.1155\/2011\/207504","volume":"2011","author":"M Gulinello","year":"2011","unstructured":"Gulinello M, Putterman C. The MRL\/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus. J Biomed Biotechnol. 2011;2011:207504.","journal-title":"J Biomed Biotechnol"},{"issue":"4","key":"628_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.neuron.2020.08.024","volume":"108","author":"FB Shipley","year":"2020","unstructured":"Shipley FB, Dani N, Xu H, Deister C, Cui J, Head JP, et al. Tracking Calcium Dynamics and Immune Surveillance at the Choroid Plexus Blood-Cerebrospinal Fluid Interface. Neuron. 2020;108(4):623\u2013e3910.","journal-title":"Neuron"},{"key":"628_CR28","doi-asserted-by":"publisher","first-page":"108478","DOI":"10.1016\/j.jneumeth.2019.108478","volume":"329","author":"U Erb","year":"2020","unstructured":"Erb U, Schwerk C, Schroten H, Karremann M. Review of functional in vitro models of the blood-cerebrospinal fluid barrier in leukaemia research. J Neurosci Methods. 2020;329:108478.","journal-title":"J Neurosci Methods"},{"key":"628_CR29","doi-asserted-by":"crossref","unstructured":"Petersen N, Torz L, Jensen KHR, Hjort\u00f8 GM, Spiess K, Rosenkilde MM. Three-dimensional explant platform for studies on Choroid Plexus Epithelium. Front Cell Neurosci. 2020;14(108).","DOI":"10.3389\/fncel.2020.00108"},{"issue":"1","key":"628_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3899\/jrheum.090194","volume":"37","author":"H Cash","year":"2010","unstructured":"Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, et al. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. J Rheumatol. 2010;37(1):60\u201370.","journal-title":"J Rheumatol"},{"issue":"3","key":"628_CR31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0090-1229(90)90051-Q","volume":"54","author":"JE Brick","year":"1990","unstructured":"Brick JE, Ong SH, Bathon JM, Walker SE, O\u2019Sullivan FX, DiBartolomeo AG. Anti-histone antibodies in the serum of autoimmune MRL and NZB\/NZW1 F1 mice. Clin Immunol Immunopathol. 1990;54(3):372\u201381.","journal-title":"Clin Immunol Immunopathol"},{"key":"628_CR32","doi-asserted-by":"publisher","first-page":"103134","DOI":"10.1016\/j.jaut.2023.103134","volume":"142","author":"JA Reynolds","year":"2024","unstructured":"Reynolds JA, Li Y, Herlitz L, Mohan C, Putterman C. Novel biomarker discovery through comprehensive proteomic analysis of lupus mouse serum. J Autoimmun. 2024;142:103134.","journal-title":"J Autoimmun"},{"issue":"1\u20132","key":"628_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jneuroim.2010.07.020","volume":"229","author":"HX Gao","year":"2010","unstructured":"Gao HX, Sanders E, Tieng AT, Putterman C. Sex and autoantibody titers determine the development of neuropsychiatric manifestations in lupus-prone mice. J Neuroimmunol. 2010;229(1\u20132):112\u201322.","journal-title":"J Neuroimmunol"},{"issue":"11","key":"628_CR34","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1002\/art.42252","volume":"74","author":"E Moore","year":"2022","unstructured":"Moore E, Huang MW, Reynolds CA, Macian F, Putterman C. Choroid Plexus-infiltrating T cells as drivers of murine neuropsychiatric lupus. Arthritis Rheumatol. 2022;74(11):1796\u2013807.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"628_CR35","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/WNL.36.7.900","volume":"36","author":"J Herbert","year":"1986","unstructured":"Herbert J, Wilcox JN, Pham KT, Fremeau RT Jr., Zeviani M, Dwork A, et al. Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award. Neurology. 1986;36(7):900\u201311.","journal-title":"Neurology"},{"key":"628_CR36","doi-asserted-by":"publisher","first-page":"101383","DOI":"10.1016\/j.scr.2019.101383","volume":"35","author":"M Bardenbacher","year":"2019","unstructured":"Bardenbacher M, Ruder B, Britzen-Laurent N, Schmid B, Waldner M, Naschberger E, et al. Permeability analyses and three dimensional imaging of interferon gamma-induced barrier disintegration in intestinal organoids. Stem Cell Res. 2019;35:101383.","journal-title":"Stem Cell Res"},{"issue":"1","key":"628_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","volume":"18","author":"CT Rueden","year":"2017","unstructured":"Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics. 2017;18(1):529.","journal-title":"BMC Bioinformatics"},{"key":"628_CR38","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fphys.2012.00166","volume":"3","author":"N Muradashvili","year":"2012","unstructured":"Muradashvili N, Tyagi R, Lominadze D. A dual-tracer method for differentiating transendothelial transport from paracellular leakage in vivo and in vitro. Front Physiol. 2012;3:166.","journal-title":"Front Physiol"},{"issue":"1","key":"628_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0014-4835(87)80027-1","volume":"44","author":"M Araie","year":"1987","unstructured":"Araie M, Maurice D. The rate of diffusion of fluorophores through the corneal epithelium and stroma. Exp Eye Res. 1987;44(1):73\u201387.","journal-title":"Exp Eye Res"},{"key":"628_CR40","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/978-3-7643-8550-7_47","volume-title":"Compendium of Inflammatory diseases","author":"KD Pile","year":"2016","unstructured":"Pile KD, Graham GG. Methotrexate. In: Parnham MJ, editor. Compendium of Inflammatory diseases. Basel: Springer Basel; 2016. pp. 934\u201342."},{"key":"628_CR41","doi-asserted-by":"crossref","unstructured":"Au - Bardenbacher M, Au - Ruder B, Au - Britzen-Laurent N, Au - Naschberger E et al. Au - Becker C, Au - Palmisano R,. Investigating Intestinal Barrier Breakdown in Living Organoids. JoVE. 2020(157):e60546.","DOI":"10.3791\/60546-v"},{"issue":"13","key":"628_CR42","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1182\/blood-2009-05-220004","volume":"114","author":"S Piconese","year":"2009","unstructured":"Piconese S, Gri G, Tripodo C, Musio S, Gorzanelli A, Frossi B, et al. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40\/OX40L axis toward Th17-cell differentiation. Blood. 2009;114(13):2639\u201348.","journal-title":"Blood"},{"issue":"1","key":"628_CR43","doi-asserted-by":"publisher","first-page":"1601955","DOI":"10.1080\/21688370.2019.1601955","volume":"7","author":"EM Danielsen","year":"2019","unstructured":"Danielsen EM, Hansen GH. Probing paracellular -versus transcellular tissue barrier permeability using a gut mucosal explant culture system. Tissue Barriers. 2019;7(1):1601955.","journal-title":"Tissue Barriers"},{"issue":"8","key":"628_CR44","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1038\/jid.2008.16","volume":"128","author":"RB Warren","year":"2008","unstructured":"Warren RB, Smith RL, Campalani E, Eyre S, Smith CH, Barker JNWN, et al. Genetic variation in Efflux Transporters Influences Outcome to Methotrexate Therapy in patients with psoriasis. J Invest Dermatology. 2008;128(8):1925\u20139.","journal-title":"J Invest Dermatology"},{"issue":"11","key":"628_CR45","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1038\/s41401-020-00602-3","volume":"42","author":"T Wu","year":"2021","unstructured":"Wu T, Sheng Y, Qin YY, Kong WM, Jin MM, Yang HY, et al. Bile duct ligation causes opposite impacts on the expression and function of BCRP and P-gp in rat brain partly via affecting membrane expression of ezrin\/radixin\/moesin proteins. Acta Pharmacol Sin. 2021;42(11):1942\u201350.","journal-title":"Acta Pharmacol Sin"},{"issue":"10","key":"628_CR46","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1124\/dmd.121.000505","volume":"49","author":"X Chen","year":"2021","unstructured":"Chen X, Unadkat JD, Mao Q. Tetrahydrocannabinol and its major metabolites are not (or are poor) substrates or inhibitors of human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and breast Cancer resistance protein (ABCG2). Drug Metab Dispos. 2021;49(10):910\u20138.","journal-title":"Drug Metab Dispos"},{"key":"628_CR47","doi-asserted-by":"crossref","unstructured":"Morris ME, Rodriguez-Cruz V, Felmlee MA, SLC, Transporters ABC. Expression, localization, and species differences at the blood-brain and the blood-cerebrospinal fluid barriers. Aaps j. 2017;19(5):1317\u201331.","DOI":"10.1208\/s12248-017-0110-8"},{"issue":"3","key":"628_CR48","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1124\/dmd.108.023630","volume":"37","author":"M Le Vee","year":"2009","unstructured":"Le Vee M, Lecureur V, Stieger B, Fardel O. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab Dispos. 2009;37(3):685\u201393.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"628_CR49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12987-022-00391-3","volume":"19","author":"V Sangha","year":"2022","unstructured":"Sangha V, Hoque MT, Henderson JT, Bendayan R. Novel localization of folate transport systems in the murine central nervous system. Fluids Barriers CNS. 2022;19(1):92.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"628_CR50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/1097-0215(20010101)91:1<120::AID-IJC1021>3.0.CO;2-Y","volume":"91","author":"DS Cowan","year":"2001","unstructured":"Cowan DS, Tannock IF. Factors that influence the penetration of methotrexate through solid tissue. Int J Cancer. 2001;91(1):120\u20135.","journal-title":"Int J Cancer"},{"issue":"6","key":"628_CR51","first-page":"1709","volume":"50","author":"GB Henderson","year":"1990","unstructured":"Henderson GB, Strauss BP. Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant L1210 cells. Cancer Res. 1990;50(6):1709\u201314.","journal-title":"Cancer Res"},{"issue":"1","key":"628_CR52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1152\/physrev.00025.2013","volume":"95","author":"SK Nigam","year":"2015","unstructured":"Nigam SK, Bush KT, Martovetsky G, Ahn SY, Liu HC, Richard E, et al. The organic anion transporter (OAT) family: a systems biology perspective. Physiol Rev. 2015;95(1):83\u2013123.","journal-title":"Physiol Rev"},{"issue":"23","key":"628_CR53","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1002\/1873-3468.13983","volume":"594","author":"M Geisler","year":"2020","unstructured":"Geisler M, Heged\u0171s T. A twist in the ABC: regulation of ABC transporter trafficking and transport by FK506-binding proteins. FEBS Lett. 2020;594(23):3986\u20134000.","journal-title":"FEBS Lett"},{"issue":"4","key":"628_CR54","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2174\/138920111795164075","volume":"12","author":"EI Stolarczyk","year":"2011","unstructured":"Stolarczyk EI, Reiling CJ, Paumi CM. Regulation of ABC transporter function via phosphorylation by protein kinases. Curr Pharm Biotechnol. 2011;12(4):621\u201335.","journal-title":"Curr Pharm Biotechnol"},{"issue":"5","key":"628_CR55","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1124\/dmd.118.080663","volume":"46","author":"RR Crawford","year":"2018","unstructured":"Crawford RR, Potukuchi PK, Schuetz EG, Schuetz JD. Beyond competitive inhibition: regulation of ABC transporters by Kinases and Protein-Protein Interactions as potential mechanisms of drug-drug interactions. Drug Metab Dispos. 2018;46(5):567\u201380.","journal-title":"Drug Metab Dispos"},{"issue":"18","key":"628_CR56","doi-asserted-by":"publisher","first-page":"16304","DOI":"10.1074\/jbc.M212321200","volume":"278","author":"X Yu","year":"2003","unstructured":"Yu X, Kennedy RH, Liu SJ. JAK2\/STAT3, not ERK1\/2, mediates interleukin-6-induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes. J Biol Chem. 2003;278(18):16304\u20139.","journal-title":"J Biol Chem"},{"issue":"7","key":"628_CR57","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/ijc.23261","volume":"122","author":"B Wegiel","year":"2008","unstructured":"Wegiel B, Bjartell A, Culig Z, Persson JL. Interleukin-6 activates PI3K\/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival. Int J Cancer. 2008;122(7):1521\u20139.","journal-title":"Int J Cancer"},{"issue":"5","key":"628_CR58","doi-asserted-by":"publisher","first-page":"e0178232","DOI":"10.1371\/journal.pone.0178232","volume":"12","author":"T Nishikai-Yan Shen","year":"2017","unstructured":"Nishikai-Yan Shen T, Kanazawa S, Kado M, Okada K, Luo L, Hayashi A, et al. Interleukin-6 stimulates akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice. PLoS ONE. 2017;12(5):e0178232.","journal-title":"PLoS ONE"},{"issue":"3","key":"628_CR59","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/intimm\/3.3.273","volume":"3","author":"B Tang","year":"1991","unstructured":"Tang B, Matsuda T, Akira S, Nagata N, Ikehara S, Hirano T, et al. Age-associated increase in interleukin 6 in MRL\/lpr mice. Int Immunol. 1991;3(3):273\u20138.","journal-title":"Int Immunol"},{"issue":"6","key":"628_CR60","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1093\/annonc\/mdt008","volume":"24","author":"C Vulsteke","year":"2013","unstructured":"Vulsteke C, Lambrechts D, Dieudonn\u00e9 A, Hatse S, Brouwers B, van Brussel T, et al. Genetic variability in the multidrug resistance associated protein-1 (ABCC1\/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC). Ann Oncol. 2013;24(6):1513\u201325.","journal-title":"Ann Oncol"},{"issue":"8","key":"628_CR61","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/gtc.13035","volume":"28","author":"M Yamamura","year":"2023","unstructured":"Yamamura M, Hanamura K, Koganezawa N, Furubayashi S, Shirao T, Kawabe H. Impacts of methotrexate on survival, dendrite development, and synapse formation of cortical neurons. Genes Cells. 2023;28(8):563\u201372.","journal-title":"Genes Cells"},{"issue":"9","key":"628_CR62","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1200\/JCO.2013.53.0808","volume":"32","author":"D Bhojwani","year":"2014","unstructured":"Bhojwani D, Sabin ND, Pei D, Yang JJ, Khan RB, Panetta JC, et al. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol. 2014;32(9):949\u201359.","journal-title":"J Clin Oncol"},{"issue":"20","key":"628_CR63","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1016\/j.neuron.2022.08.009","volume":"110","author":"A Jang","year":"2022","unstructured":"Jang A, Petrova B, Cheong TC, Zawadzki ME, Jones JK, Culhane AJ, et al. Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy. Neuron. 2022;110(20):3288\u2013e3018.","journal-title":"Neuron"},{"key":"628_CR64","doi-asserted-by":"crossref","unstructured":"Ibrahim KM, Darwish SF, Mantawy EM, El-Demerdash E. Molecular mechanisms underlying cyclophosphamide-induced cognitive impairment and strategies for neuroprotection in preclinical models. Mol Cell Biochem. 2023.","DOI":"10.1007\/s11010-023-04805-0"},{"issue":"5","key":"628_CR65","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0092-8674(00)00179-3","volume":"103","author":"DF Robbiani","year":"2000","unstructured":"Robbiani DF, Finch RA, J\u00e4ger D, Muller WA, Sartorelli AC, Randolph GJ. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell. 2000;103(5):757\u201368.","journal-title":"Cell"},{"issue":"3","key":"628_CR66","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.neuroscience.2006.02.051","volume":"140","author":"SH Fang","year":"2006","unstructured":"Fang SH, Wei EQ, Zhou Y, Wang ML, Zhang WP, Yu GL, et al. Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats. Neuroscience. 2006;140(3):969\u201379.","journal-title":"Neuroscience"},{"key":"628_CR67","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuropharm.2013.06.014","volume":"73","author":"KH Kang","year":"2013","unstructured":"Kang KH, Liou HH, Hour MJ, Liou HC, Fu WM. Protection of dopaminergic neurons by 5-lipoxygenase inhibitor. Neuropharmacology. 2013;73:380\u20137.","journal-title":"Neuropharmacology"},{"issue":"1","key":"628_CR68","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s40478-020-00989-4","volume":"8","author":"J Michael","year":"2020","unstructured":"Michael J, Unger MS, Poupardin R, Schernthaner P, Mrowetz H, Attems J, et al. Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer\u2019s disease mice. Acta Neuropathol Commun. 2020;8(1):129.","journal-title":"Acta Neuropathol Commun"},{"key":"628_CR69","doi-asserted-by":"publisher","first-page":"853000","DOI":"10.3389\/fimmu.2022.853000","volume":"13","author":"S Attaluri","year":"2022","unstructured":"Attaluri S, Upadhya R, Kodali M, Madhu LN, Upadhya D, Shuai B, et al. Brain-specific increase in Leukotriene Signaling accompanies chronic neuroinflammation and cognitive impairment in a model of Gulf War Illness. Front Immunol. 2022;13:853000.","journal-title":"Front Immunol"},{"issue":"5","key":"628_CR70","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1139\/y82-096","volume":"60","author":"RJ Riopelle","year":"1982","unstructured":"Riopelle RJ, Kennedy JC. Some aspects of porphyrin neurotoxicity in vitro. Can J Physiol Pharmacol. 1982;60(5):707\u201314.","journal-title":"Can J Physiol Pharmacol"},{"issue":"11","key":"628_CR71","doi-asserted-by":"publisher","first-page":"e2389","DOI":"10.1002\/brb3.2389","volume":"11","author":"LM Gerischer","year":"2021","unstructured":"Gerischer LM, Scheibe F, N\u00fcmann A, K\u00f6hnlein M, St\u00f6lzel U, Meisel A. Acute porphyrias - a neurological perspective. Brain Behav. 2021;11(11):e2389.","journal-title":"Brain Behav"},{"issue":"10","key":"628_CR72","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1002\/art.11279","volume":"48","author":"E Trysberg","year":"2003","unstructured":"Trysberg E, Nylen K, Rosengren LE, Tarkowski A. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum. 2003;48(10):2881\u20137.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"628_CR73","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41392-021-00867-y","volume":"7","author":"X Han","year":"2022","unstructured":"Han X, Xu T, Ding C, Wang D, Yao G, Chen H, et al. Neuronal NR4A1 deficiency drives complement-coordinated synaptic stripping by microglia in a mouse model of lupus. Signal Transduct Target Ther. 2022;7(1):50.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"628_CR74","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/brain\/aww031","volume":"139","author":"E Ercan","year":"2016","unstructured":"Ercan E, Magro-Checa C, Valabregue R, Branzoli F, Wood ET, Steup-Beekman GM, et al. Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites. Brain. 2016;139(5):1447\u201357.","journal-title":"Brain"},{"issue":"3","key":"628_CR75","doi-asserted-by":"publisher","first-page":"443","DOI":"10.46497\/ArchRheumatol.2020.7544","volume":"35","author":"MI Sarbu","year":"2020","unstructured":"Sarbu MI, Sarbu N. Fulminant brain atrophy and Vasculitis on Vessel-Wall Imaging in Neuropsychiatric Lupus: Case Report and Literature Review. Arch Rheumatol. 2020;35(3):443\u20138.","journal-title":"Arch Rheumatol"},{"issue":"11","key":"628_CR76","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1016\/j.cell.2021.04.003","volume":"184","author":"N Dani","year":"2021","unstructured":"Dani N, Herbst RH, McCabe C, Green GS, Kaiser K, Head JP, et al. A cellular and spatial map of the choroid plexus across brain ventricles and ages. Cell. 2021;184(11):3056\u2013e7421.","journal-title":"Cell"},{"issue":"1","key":"628_CR77","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1152\/physrev.00060.2021","volume":"103","author":"NR Saunders","year":"2023","unstructured":"Saunders NR, Dziegielewska KM, Fame RM, Lehtinen MK, Liddelow SA. The choroid plexus: a missing link in our understanding of brain development and function. Physiol Rev. 2023;103(1):919\u201356.","journal-title":"Physiol Rev"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00628-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-025-00628-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00628-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T15:01:05Z","timestamp":1739286065000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-025-00628-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1186\/s12987-025-00628-x","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"10 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval regarding human participants was not required, as no patient samples or data were used in conducting this study. All animal welfare policies and procedures were approved by the Institutional Animal Care and Use Committees at the Albert Einstein College of Medicine (New York). Study reporting and conduct followed the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No authors have competing interests, financial or otherwise. At the time of conducting the study, L.T. was an employee of Novo Nordisk A\/S.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Graphics used in Fig.\u00a01A\u00a0A-C were generated using Biorender online software. Reproduction licenses were granted and are available upon request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Production of graphics and image licenses"}}],"article-number":"15"}}